NEW YORK (GenomeWeb News) – Fluidigm yesterday said that its manufacturing facility in Singapore has begun working at full process ahead of schedule.
The facility, which opened its doors less than one year ago, was to reach this level by the end of 2006, a Fluidigm spokesperson said.
The facility manufactures BioMark dynamic arrays, among other products, which are integrated fluidic circuits that are designed to increase qPCR efficiency. Fluidigm will sell these products to study genetic and protein biomarkers.
Other chips currently being developed “address multi-step processes on a nanovolume scale, including synthesis of imaging probes used in positron emission tomography and the preparation of nucleic acids for analysis,” Fluidigm said in a statement.